1 Min Read
March 16 (Reuters) - Kalvista Pharmaceuticals Inc
* Kalvista Pharmaceuticals reports fiscal third quarter results
* Q3 loss per share $1.03
* Q3 revenue $200,000 versus $300,000 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.